BGI Europe A/S, a completely owned subsidiary of BGI Genomics, introduced its NIFTY® non-invasive prenatal testing equipment and software program (CE-IVDD Checklist B) have been granted an extension below its current CE-IVDD certification to incorporate the DNBSEQ-G99 mannequin to satisfy the European Union rules for medical units.
In January 2024, BGI Genomics unveiled the NIFTY® ultra-fast non-invasive prenatal genetic testing product, using the progressive DNBSEQ-G99 platform. Designed for each small and medium throughput, this platform ensures top-notch testing efficiency and high quality. It permits medical laboratories to supply faster and extra correct prenatal genetic testing outcomes. This development is essential for well timed genetic counseling and additional prenatal prognosis, enhancing prenatal care choices.
Key options of the DNBSEQ-G99 platform:
Velocity: The DNBSEQ-G99 platform dramatically reduces sequencing time to only 3 hours, with all the course of from pattern assortment to report era taking solely 14 hours. This effectivity considerably reduces the anxious anticipate anticipating households.
Flexibility: It permits for the processing of various pattern sizes in a single run, accommodating a minimal of 12 samples. This flexibility helps in minimizing reagent waste and slicing prices.
Versatility: The platform helps varied sequencing modes and is appropriate for a variety of checks, together with pre-embryo transplantation chromosome testing and monogenic illness service screening.
Simplicity: That includes a cassette stream cell and an progressive pre-injected reagent design, the DNBSEQ-G99 simplifies the sequencing course of, making it user-friendly for operators.
BGI Genomics has been a pioneer in non-invasive prenatal genetic testing since 2010. NIFTY® has obtained medical system {qualifications} in varied international locations, together with the UK, Australia, Saudi Arabia, Turkey, India, and Thailand. BGI Genomics continues to improve its prenatal and neonatal checks, contributing to raised public well being programs and outcomes.
Guided by the imaginative and prescient of “Omics for all,” BGI Genomics is devoted to enhancing genetic testing applied sciences, thereby advancing world precision drugs and enhancing lives.
